Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Abeona Therapeutics Inc Is A Commercial-Stage Biopharmaceutical Company. The Company Is Focused On Developing Cell And Gene Therapies For Life-Threatening Diseases. The Company'S Zevaskyn (Prademagene Zamikeracel) Is An Autologous Cell-Based Gene Therapy For The Treatment Of Wounds In Adults And Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa (Rdeb). The Company'S Development Portfolio Includes Adeno-Associated Virus (Aav)-Based Gene Therapies For Ophthalmic Diseases With High Unmet Medical Need.